Despite being a proven life-saving treatment, 1 in 5 Australians who need radiotherapy never receive it. This year, on September 7, the first-ever World Radiotherapy Awareness Day will be launched, ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. The study shows that ...

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, opening new possibilities for cancer therapy. This breakthrough addresses the ...

This medication is a beneficial addition to your prostate cancer treatment plan — but it doesn’t come without risks. Here’s how to stay ahead of potential side effects. If you’ve been diagnosed with ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Common side effects or impacts of treatment ...

While hormone therapy can be an effective type of cancer treatment, it often causes side effects. It’s important to know about possible side effects when making treatment decisions. It's also ...

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell lung cancer and brain metastases, finding they ...

Finishing cancer treatment is a major milestone, and many people feel relief and hope once it’s over. But for many cancer survivors, the end of treatment is not the end of the journey. While ...

Matthew Herper covers medical innovation — both its promise and its perils. The biotech firm Nuvalent said Tuesday that new data indicate its targeted drug zidesamtinib could help patients with a rare ...

Radiation therapy targets lung cancer at all stages, damaging tumor cell DNA to inhibit growth and division. Palliative radiation focuses on symptom relief in polymetastatic disease, using shorter, ...

Evaluation of longitudinal image-derived AI prognostication as a predictor of overall survival (OS) in a phase 3 advanced non-small cell lung cancer (aNSCLC) trial. Transforming oncology clinical ...